Microba Life Sciences【MAP】銘柄情報

Microba Life Sciences Ltd (MAP) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.039

( -2.50% )

買値

0.038

売値

0.04

出来高

335,072

0.039 日の範囲 0.04

0.037 52 週間の範囲 0.105

時価総額

23.75M

前日終値

0.04

始値

0.04

時刻

122889

0.039

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

AUD 836,298

発行済株式数

608,963,034

配当利回り

PER

-1.05

1 株当たり利益 (EPS)

-0.04

歳入

14.9M

純利益

-19.75M

Microba Life Sciences Limited provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland. It operates in two segments, Testing Services and Supplements, and Research and Develop... Microba Life Sciences Limited provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland. It operates in two segments, Testing Services and Supplements, and Research and Development. The company also develops pathology, therapeutics, and diagnostics services based on the human gut microbiome. In addition, it offers MetaPanel, a metagenomic test for pathogen detection; MetaXplore that provides a range of diagnostics solution under the Co-Biome brand; research testing services; and data-driven therapeutics platform that develops therapies for ulcerative colitis, and inflammatory bowel and autoimmune diseases, as well as microbiome databank. Microba Life Sciences Limited was incorporated in 2017 and is based in Brisbane, Australia. 詳細を表示

セクター

Healthcare

業界

Medical Diagnostics & Screening

ウェブサイト

microba.com

本社

Brisbane, Australia

設立

2026

Microba Life Sciences Ltd is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker MAP. The last closing price for Microba Life Sciences was AUD0.04. Over the last year, Microba Life Sciences shares have traded in a share price range of AUD 0.037 to AUD 0.105.

Microba Life Sciences currently has 608,963,034 shares in issue. The market capitalisation of Microba Life Sciences is AUD23.75 million. Microba Life Sciences has a price to earnings ratio (PE ratio) of -1.05.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.039	0.043	0.037	757742	0.04024415	DE
4	-0.014	-26.4150943396	0.053	0.053	0.037	1404574	0.04065117	DE
12	-0.03	-43.4782608696	0.069	0.082	0.037	667605	0.052807	DE
26	-0.036	-48	0.075	0.105	0.037	456678	0.06491217	DE
52	-0.046	-54.1176470588	0.085	0.105	0.037	434855	0.07428306	DE
156	-0.261	-87	0.3	0.45	0.037	302517	0.1409933	DE
260	-0.401	-91.1363636364	0.44	0.45	0.037	313737	0.19070802	DE